My Treatment Approach: Expanding Treatment Options for Relapsed/Refractory Follicular Lymphoma : Episode 8
Relapsed/Refractory Follicular Lymphoma: EZH2- and PIK3-Targeted Therapies
A brief discussion on the respective roles of EZH2- and PI3K-targeted therapies in patients with relapsed/refractory follicular lymphoma.
EP: 1.Recent Treatment Guideline Updates in Follicular Lymphoma
EP: 2.Evolving Treatment Landscape of Relapsed/Refractory Follicular Lymphoma
EP: 3.Patient Scenario 1: An 83 -Year-Old With Relapsed/Refractory FL
EP: 4.Role of BTK Inhibitors in Relapsed/Refractory Follicular Lymphoma
EP: 5.First-Line Treatment Options for Patients With Follicular Lymphoma
EP: 6.Follicular Lymphoma: Patient Monitoring and Maintenance Therapy
EP: 7.Relapsed/Refractory Follicular Lymphoma Treatment Armamentarium
Now Viewing
EP: 8.Relapsed/Refractory Follicular Lymphoma: EZH2- and PIK3-Targeted Therapies
EP: 9.Patient Scenario 2: A 53-Year-Old Man With Relapsed/Refractory FL
EP: 10.Relapsed/Refractory Follicular Lymphoma: Future Directions in Care
Related Videos
Related Content
